JETA Molecular at EFI 2022 Congress in Amsterdam

JETA Molecular at EFI 2022 Congress in Amsterdam

JETA Molecular is participating at the upcoming EFI 2022 meeting held on May 17-20, 2022 in Amsterdam. We are looking forward to meeting our customers, business partners and friends at our booth nr. 15.

Results of our four-color genotyping and monitoring analyses using the QIAcuity Digital PCR System (QIAGEN) as well as data evaluating performance of QTRACE® (qPCR; relative quantification) and DigitalTRACE™ (dPCR; absolute quantification) in various EPT trials will be presented here:

Zamostna B., Mak C., Jiroutek P. and Bost D. (2022): A Four-color Digital PCR-based Method for Accurate DNA Genotyping and Sensitive Chimerism Analysis

Zamostna B., Mak C., Jiroutek P. and Bost D. (2022): External proficiency testing as a tool for evaluation
of the accuracy of relative and absolute quantification in chimerism analysis

Read More

The World's first HoloGRAFT™ demo at Children´s Hospital of Philadelphia

The World's first HoloGRAFT™ demo at Children´s Hospital of Philadelphia

The HoloGRAFT™ kit, developed by JETA Molecular in cooperation with Omixon, detects cell-free, donor-derived circulating DNA as a biomarker of organ health after transplantation using the highly sensitive digital PCR (dPCR) technology. On April 11, 2022, the dPCR experts from JETA Molecular organized the World´s first demo at Children´s Hospital of Philadelphia (CHOP), US, using the QIAcuity Digital PCR System.

Read More